Almac Group Hosts Internationally Recognized Chemistry R&D Forum in Belfast

November 15, 2022

Nordic-Irish Process Chemistry Conference re-scheduled to June 2023

Almac Sciences, a member of the Almac Group, has announced that the Nordic Process Chemistry Forum, an internationally recognized forum for leaders in chemistry, will be held in Belfast, Northern Ireland for the very first time in the forum’s history. Traditionally hosted by Nordic-based companies, this move has resulted in the forum being renamed to the Nordic-Irish Process Chemistry Forum in advance of the event, which was originally scheduled to run in May 2020 but rescheduled due to the global COVID-19 pandemic.

As a leader in process chemistry and R&D, Almac Sciences will serve as the host during the forum from 6th to 8th  June 2023. The Nordic Process Chemistry Forum has a long history of attracting some of the most respected and innovative speakers in the world of chemistry, and the Belfast event will be the 9th event forum.

Since the event was founded in 2004, by a group representing pharma company AstraZeneca and CRO/CMO Syntagon, all based in Sweden, the main driver of the forum has been to bring scientists together who are involved in the design and scale up of chemical processes. The event facilitates networking, addresses pertinent chemical challenges, and fosters idea sharing and hosts new chemical trends. The upcoming event in Belfast is no exception— a fantastic line-up of industrial and academic speakers has been secured for this event, covering a range of subjects within the process chemistry field. A dedicated website has been created for this event (see below) and expression of interest is now open with opportunities for participation.

Professor Tom Moody, VP Technology Development & Commercialization at Almac and Arran Chemical Company commented: “We have established excellent relationships with the Nordic Process Chemistry industry and are delighted to be entrusted to host this event in Northern Ireland. The rich chemistry expertise and innovative research taking place among industry and academia across the EU and within the island of Ireland will be showcased this at the event. We are delighted to re-schedule this prestigious event and look forward to hosting our guests in Belfast where chemistry will be brought to life.”

Professor Hans-Jurgen Federsel, co-Founder of the Nordics forum, said: “The basic idea behind starting the Nordic Process Chemistry Forum was the feeling that this part of the world was in dire need of a meeting where chemists, notably active in an industrial setting, could meet biannually and share top scientific and technical achievements. Unfortunately, the global pandemic prevented the 2020 event going ahead but I’m personally very happy that my friends at Almac have remained committed to re-organizing the event which will be hosted for the first time outside the realm of the original Nordic countries.”

The Nordic Irish Process Chemistry Forum will be held from 6 – 8 June 2023 at W5, Belfast, Northern Ireland. Visit the dedicated webpage at to register interest and find out more participation opportunities.


About Almac Group

A unique culture delivering exceptional solutions

The Almac Group is an established contract development and manufacturing organization providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.

Our innovative services range from R&D, biomarker discovery development and commercialization, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organization that has grown organically over the past five decades now employing over 5,000 highly skilled personnel across 17 facilities including Europe, the US and Asia.

We have a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.

To keep up to date with our latest news, follow us on Twitter and LinkedIn or visit


Back to news